<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02863341</url>
  </required_header>
  <id_info>
    <org_study_id>2016/00422</org_study_id>
    <nct_id>NCT02863341</nct_id>
  </id_info>
  <brief_title>Nursing Home Team-Care Deprescribing Study</brief_title>
  <official_title>Nursing Home Team-Care Deprescribing Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tan Tock Seng Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Monash University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Healthcare Group, Singapore</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Tan Tock Seng Hospital</source>
  <brief_summary>
    <textblock>
      This is a multi-centre study in Singapore nursing homes, investigating the factors that
      affecting deprescribing, and if a team-care based deprescribing standard practice gives
      superior health and pharmacoeconomic outcomes over current medication review practice.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2016</start_date>
  <completion_date type="Actual">April 2018</completion_date>
  <primary_completion_date type="Actual">March 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in Fall Risk Assessment Tool (FRAT) score</measure>
    <time_frame>Change from baseline in FRAT score at 3 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in Fall Risk Assessment Tool (FRAT) score</measure>
    <time_frame>Change from baseline in FRAT score at 6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in Fall Risk Assessment Tool (FRAT) score</measure>
    <time_frame>Change from baseline in FRAT score at 12 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in fall rate</measure>
    <time_frame>Change from baseline in fall rate at 3 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in fall rate</measure>
    <time_frame>Change from baseline in fall rate at 6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in fall rate</measure>
    <time_frame>Change from baseline in fall rate at 12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Factors affecting deprescribing</measure>
    <time_frame>0 month</time_frame>
    <description>Interview questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in mean number of medications per subject</measure>
    <time_frame>Change from baseline in mean number of medications per subject at 3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in mean number of medications per subject</measure>
    <time_frame>Change from baseline in mean number of medications per subject at 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in mean number of medications per subject</measure>
    <time_frame>Change from baseline in mean number of medications per subject at 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in mean medication cost per subject</measure>
    <time_frame>Change from baseline in mean medication cost at 3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in mean medication cost per subject</measure>
    <time_frame>Change from baseline in mean medication cost at 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in mean medication cost per subject</measure>
    <time_frame>Change from baseline in mean medication cost at 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in deprescribing intervention acceptance rate</measure>
    <time_frame>Change from baseline in deprescribing intervention acceptance rate at 3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in deprescribing intervention acceptance rate</measure>
    <time_frame>Change from baseline in deprescribing intervention acceptance rate at 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in deprescribing intervention acceptance rate</measure>
    <time_frame>Change from baseline in deprescribing intervention acceptance rate at 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in percentage of drug-related problems (DRPs)</measure>
    <time_frame>Change from baseline in percentage of DRPs at 3 months</time_frame>
    <description>Medication review form (Hepler/Strand DRP classification system)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in percentage of drug-related problems (DRPs)</measure>
    <time_frame>Change from baseline in percentage of DRPs at 6 months</time_frame>
    <description>Medication review form (Hepler/Strand DRP classification system)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in percentage of drug-related problems (DRPs)</measure>
    <time_frame>Change from baseline in percentage of DRPs at 12 months</time_frame>
    <description>Medication review form (Hepler/Strand DRP classification system)</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">295</enrollment>
  <condition>Fall in Nursing Home</condition>
  <condition>Medication Therapy Management</condition>
  <arm_group>
    <arm_group_label>naive Deprescribing arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Team-based deprescribing practice, Deprescribing Guide</description>
  </arm_group>
  <arm_group>
    <arm_group_label>naive Wait-list Control arm</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>non-naive Deprescribing arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Team-based deprescribing practice, Deprescribing Guide</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non-naive Wait-list Control arm</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Team-care deprescribing with deprescribing guide</intervention_name>
    <description>Beers criteria 2015, STOPP criteria 2014, drug interaction</description>
    <arm_group_label>naive Deprescribing arm</arm_group_label>
    <arm_group_label>non-naive Deprescribing arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        For interview questionnaire:

        Inclusion criteria are:

          1. Accepted informed consent,

          2. The healthcare professional is practicing in the involved nursing homes.

        Exclusion criteria are:

        1) Decline/unable to provide consent.

        For team-care deprescribing study:

        Inclusion criteria are:

          1. Accepted informed consent (unless cognitive-impaired, with no or un-contactable
             next-of-kin),

          2. Adult aged 65 years and above,

          3. Currently on five or more medications.

        Exclusion criteria are:

          1. Below the age of 65 years of age,

          2. Life expectancy of less than 6 months or respite care.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chong Han Kua</last_name>
    <role>Principal Investigator</role>
    <affiliation>Monash University/Tan Tock Seng Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Nursing homes</name>
      <address>
        <city>Singapore</city>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Singapore</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 31, 2016</study_first_submitted>
  <study_first_submitted_qc>August 7, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 11, 2016</study_first_posted>
  <last_update_submitted>April 3, 2018</last_update_submitted>
  <last_update_submitted_qc>April 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 5, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tan Tock Seng Hospital</investigator_affiliation>
    <investigator_full_name>Kua Chong Han</investigator_full_name>
    <investigator_title>PhD Intern</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

